Jaguar Health, Inc.

Jaguar Health, Inc.verified

JAGX

Price:

$0.9767

Market Cap:

$11.52M

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for shor...[Read more]

Industry

Biotechnology

IPO Date

2015-05-12

Stock Exchange

NASDAQ

Ticker

JAGX

The ROE as of December 2024 (TTM) for Jaguar Health, Inc. (JAGX) is -287.85%

According to Jaguar Health, Inc.’s latest financial reports and current stock price. The company's current ROE is -287.85%. This represents a change of 211.28% compared to the average of -92.47% of the last 4 quarters.

Jaguar Health, Inc. (JAGX) Historical ROE (quarterly & annually)

How has JAGX ROE performed in the past?

The mean historical ROE of Jaguar Health, Inc. over the last ten years is 401.67%. The current -287.85% ROE has changed -171.66% with respect to the historical average. Over the past ten years (40 quarters), JAGX's ROE was at its highest in in the September 2016 quarter at 1.25%. The ROE was at its lowest in in the June 2020 quarter at -598.32%.

Quarterly (TTM)
Annual

Average

401.67%

Median

-365.71%

Minimum

-832.49%

Maximum

7.22%

Jaguar Health, Inc. (JAGX) ROE by Quarter and Year

Discovering the peaks and valleys of Jaguar Health, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 369.20%

Maximum Annual ROE = 7.22%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -832.49%

Quarterly (TTM)
Annual
YearROEChange
2023-832.49%-111.53%
20227.22%-1491.92%
2021-518.91%142.62%
2020-213.88%-40.77%
2019-361.07%-39.54%
2018-597.16%369.20%
2017-127.27%-121.20%
2016600.35%-262.11%
2015-370.34%-52.85%
2014-785.38%-Infinity%

Jaguar Health, Inc. (JAGX) Average ROE

How has JAGX ROE performed in the past?

The current ROE of Jaguar Health, Inc. (JAGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.96%

5-year avg

1.06%

10-year avg

401.67%

Jaguar Health, Inc. (JAGX) ROE vs. Peers

How is JAGX’s ROE compared to its peers?

Jaguar Health, Inc.’s ROE is less than Onconova Therapeutics, Inc. (619.75%), greater than iBio, Inc. (-126.61%), greater than GeoVax Labs, Inc. (-809.91%), greater than Ocugen, Inc. (-154.75%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Virios Therapeutics, Inc. (-130.35%), greater than Zura Bio Limited (-39.61%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Tonix Pharmaceuticals Holding Corp. (-163.95%), greater than Acasti Pharma Inc. (-18.84%), greater than Diffusion Pharmaceuticals Inc. (-44.12%), greater than Phio Pharmaceuticals Corp. (-134.57%), greater than Sonnet BioTherapeutics Holdings, Inc. (-383.41%), greater than 180 Life Sciences Corp. (-559.06%), greater than Cardio Diagnostics Holdings, Inc. (-258.81%), greater than Vaxart, Inc. (-110.46%), greater than VBI Vaccines Inc. (-1081.80%),

Build a custom stock screener for Jaguar Health, Inc. (JAGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jaguar Health, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jaguar Health, Inc. (JAGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jaguar Health, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Jaguar Health, Inc.'s ROE?

How is the ROE calculated for Jaguar Health, Inc. (JAGX)?

What is the highest ROE for Jaguar Health, Inc. (JAGX)?

What is the 3-year average ROE for Jaguar Health, Inc. (JAGX)?

What is the 5-year average ROE for Jaguar Health, Inc. (JAGX)?

How does the current ROE for Jaguar Health, Inc. (JAGX) compare to its historical average?